aDepartment of Clinical and Experimental Medicine, School of Nephrology, University of Catania, Catania, Italy
bDepartment of Pharmacology, INSERM U970
cDepartment of Pharmacology, Assistance Publique–Hôpitaux de Paris, Hôpital Européen Georges Pompidou
dUniversité Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine
eINSERM U970, Cardiovascular Epidemiology and Sudden Cardiac Death
fPreventive and Clinical Investigation Center (IPC), Paris, France
Correspondence to Luca Zanoli, MD, PhD Nephrology, Department of Clinical and Experimental Medicine, Policlinico Universitario di Catania, University of Catania, Via Santa Sofia 78, 95123 Catania, Italy. Tel: +39 3474574122; fax: +39 0953782376; e-mail: [email protected]
Abbreviations: BP, blood pressure; CKD, chronic kidney disease; GFR, glomerular filtration rate; PPS3, Paris Prospective Study 3
Received 12 July, 2018
Accepted 29 October, 2018
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).